脑机接口医疗应用前景广阔，医保前瞻性立项助力行业发展

Investment Rating - The industry is rated as "Positive," with expectations that the overall return will exceed the CSI 300 Index by more than 5% in the next six months [8] Core Insights - The medical application of brain-computer interface (BCI) technology has a promising future, with the National Healthcare Security Administration (NHSA) establishing pricing projects for BCI technologies, paving the way for clinical applications once the technology matures [1][7] - The global potential market size for BCI in the medical field is estimated to reach between $40 billion and $145 billion by 2030-2040, with serious medical applications projected to be between $15 billion and $85 billion, and consumer medical applications between $25 billion and $60 billion [2] - Regulatory frameworks for BCI in China are maturing, with significant government support and initiatives, including the inclusion of "brain science and brain-like research" in the national key technology projects [3] Summary by Sections Industry Overview - BCI technology has made significant advancements, transitioning from laboratory research to market applications, indicating a broad development outlook [2] - The NHSA's recent guidelines for BCI pricing signify a structured approach to integrating BCI technologies into healthcare [1] Product Development - Invasive BCI products are currently in clinical stages, with companies like Neuralink conducting long-term clinical trials aimed at restoring motor functions in paralyzed patients [4] - Non-invasive BCI products are already available in the market, with applications in consumer and rehabilitation settings, such as smart sleep devices and anesthesia monitoring [4] Related Companies - Key companies in the BCI sector include Chengyitong, Xiangyu Medical, Innovation Medical, and Aipeng Medical, which are actively developing and applying BCI technologies in various medical fields [5]